Live Breaking News & Updates on Molecular Therapeutic
Stay updated with breaking news from Molecular therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cepheid Gets Health Canada License For Four-in-one Rapid Molecular Diagnostic Test WASHINGTON (dpa-AFX) - Cepheid, a unit of Danaher Corp. (DHR), said Thursday that it has received a medical device license from Health Canada for Xpert Xpress SARS-CoV-2/Flu/RSV, a rapid molecular diagnostic test for qualitative detection of the viruses causing COVID-19, Flu A, Flu B, and RSV infections from a single patient sample. The test is now available in Canada and can be used in laboratories and at the point of care. Cepheid noted that the four-in-one test is designed for use on any of the company s almost 30,000 GeneXpert Systems placed worldwide, with results delivered in approximately 36 minutes. ....
socaltech.com San Diego-based Cardea Bio, a startup that is developing molecular biology equipment which uses semiconductors to analyze samples, said on Tuesday that it has raised $6.5M more in its Series A funding. The company said the new funding was led by 3E Bioventures Capital, and also included existing investors. The company has now raised $20M in its Series The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or ....
January 10, 2021 THE Southern Philippines Medical Center (SPMC) inaugurated on Saturday, January 9, 2021, its P18-million molecular laboratory that could quadruple its testing capacity. The facility was donated by the Metrobank Foundation (MBFI) and George Ty Foundation and constructed by the Ateneo de Davao University (AdDU). The facility was formally turned over to SPMC over the weekend. The molecular facility will be conducting a real-time reverse transcription-polymerase chain reaction (RT-PCR) test of up to 200 samples a day, with a result turn-around time of three operating days. Davao City Mayor Sara Duterte-Carpio, in a statement read by Assistant City Health Officer Dr. Marjorie Culas, said the new molecular laboratory will help improve the city government s testing efforts in its Covid-19 response. ....
Viewpoint Molecular Targeting, Inc.: Viewpoint Molecular Targeting Announces Closing of Its Series A Financing with Proceeds of $13 Million ?? -NET into Phase 1 imaging studies beginning in 2021 and accelerate development of radioisotope production technologies CORALVILLE, IA / ACCESSWIRE / January 8, 2021 / Viewpoint Molecular Targeting, Inc. ( Viewpoint or the Company ), a radiopharmaceutical company developing precision α-particle oncology therapeutics and complementary diagnostic imaging agents, announced today it has closed the third and final tranche of its Series A financing for a total of approximately $13 million. Proceeds from the financing will be used to advance the Company s two lead programs, VMT01 and VMT-??-NET, into Phase 1 human clinical studies, further develop its proprietary VMT-??-GEN isotope generator, and fund general operating expenses. ....